NCT04550793

Brief Summary

Spasticity of stroke patient, a very common complication in clinical practice, affects performance of hand function and gait pattern. It also interferes with quality of life of patients severely. Currently first line clinical approach to spasticity consist of physical therapy and pharmacological management. However, there are still some refractory cases that needed local intervention such as Botox injection. So far, we only can use subjective methods to measure muscle tension, such as modified Ashworth scale and Tone Assessment Scale. In our previous study, we found that ultrasound shear wave image could correlate with muscle stiffness caused by poststroke spasticity. With this new method, we aim to establish a more objective method in measuring abnormal poststroke muscle tension before and after treatments and further monitor therapeutic effect. We also include several assessment scales to evaluate the correlation between measured muscle spasm and activity of daily living. We hypothesize that the rheological changes in muscles muscle spasm after Botox injection can be detected by ultrasound shear wave image. Therapeutic effect can also be seen in its effect on daily functions. In this project, we will use shear wave imaging of ultrasound to investigate the elasticity (and hardness) of the biceps brachii and brachialis muscle in stroke patients with unilateral hemiplegia before and after Botox injection. The findings of this project will provide the objective evaluation of muscle spasticity and its correlation with functional status, which will provide new points of view toward treatment of spasticity.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

September 9, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 16, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

September 16, 2020

Status Verified

July 1, 2020

Enrollment Period

1.2 years

First QC Date

September 9, 2020

Last Update Submit

September 9, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Shear Wave Ultrasound Elastography

    Shear wave ultrasound elastography measurement of spastic upper limb muscles, including biceps brachii and brachialis

    During each follow up visit within 12 weeks time frame

Secondary Outcomes (10)

  • Barthel Index (Wade's version)

    During each follow up visit within 12 weeks time frame

  • Revised Nottingham Extended Activities of Daily Livings Scale

    During each follow up visit within 12 weeks time frame

  • Stroke Rehabilitation Assessment of Movement (STREAM), brief version

    During each follow up visit within 12 weeks time frame

  • Modified Ashworth Scale (MAS)

    During each follow up visit within 12 weeks time frame

  • Tone Assessment Scale (TAS)

    During each follow up visit within 12 weeks time frame

  • +5 more secondary outcomes

Study Arms (2)

Intervention

The stroke patients who receive botulinum toxin injection at affected brachialis and/or biceps brachials.

Drug: Botulinum toxin injection

Control

The stroke patients who do not receive botulinum toxin injection at affected brachialis and/or biceps brachials in the past 3 months.

Interventions

Botulinum toxin injection at affected brachialis and/or biceps brachials.

Intervention

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Stroke patient aged above 20 years old with unilateral involvement.

You may qualify if:

  • \[Intervention group\]
  • Stroke patients with unilateral involvement
  • Patient's spasticity over affected upper extremities scored at least 1+ with Modified Ashworth Scale
  • Patient required botulinum toxin injection at affected upper limb muscle per primary care physician.
  • \[Control group\]
  • Stroke patients with unilateral involvement
  • Patient's spasticity over affected upper extremities scored at least 1+ with Modified Ashworth Scale

You may not qualify if:

  • Patients ever diagnosed with cerebral diseases other than stroke, such as traumatic brain injury, encephalitis and brain tumor
  • Patients failed to cooperated due to cognition, consciousness or speech problem
  • Patients with illness that could affect muscle stiffness, such as spinal cord injury and Parkinson's disease
  • Patients with upper limb contracture
  • Patients receiving botulinum toxin injection or shock wave therapy over upper extremities during past three months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

Location

MeSH Terms

Conditions

StrokeMuscle SpasticityBotulism

Interventions

Botulinum Toxins

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsClostridium InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsNeuromuscular Junction DiseasesNeuromuscular DiseasesNeurotoxicity SyndromesFoodborne DiseasesPoisoningChemically-Induced Disorders

Intervention Hierarchy (Ancestors)

MetalloendopeptidasesEndopeptidasesPeptide HydrolasesHydrolasesEnzymesEnzymes and CoenzymesMetalloproteasesBacterial ProteinsProteinsAmino Acids, Peptides, and ProteinsBacterial ToxinsToxins, BiologicalBiological Factors

Study Officials

  • Huey-Wen Liang, MD PHD

    National Taiwan University Hospital

    STUDY DIRECTOR

Central Study Contacts

Huey-Wen Liang, MD PHD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
12 Weeks
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2020

First Posted

September 16, 2020

Study Start

September 1, 2020

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

September 16, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations